To stir up support for the fight against cancer, Pfizer has turned to one of the most iconic pep talks of all time. | To stir ...
The pharma company had to scale vaccine production from 200 million annually to 3 billion at the pandemic's peak.
The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...
The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE, Mass., Jan. 8, 2026 /PRNewswire/ -- Pfizer Inc. and Boltz, PBC, an applied AI research lab, today announced ...
Analysts parsed the limited data available for Pfizer’s obesity candidate on the pharma’s fourth-quarter earnings call Tuesday, looking for any nugget of additional context.
The excitement of two COVID-19 vaccines with more than 90 percent efficacy is undeniable. In November, both Pfizer and Moderna announced its scientists had developed vaccines with efficacy at or near ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results